The objectives of this study were (1) to assess the within- and between-laboratory repeatability of a commercially available antibody-detection Ostertagia ostertagi ELISA (SVANOVIR(O). ostertagi-Ab, Svanova, Uppsala) and (2) to investigate if the assay could be further simplified by reading optical density at a single instead of double wavelength. A total of 80 bulk-tank milk samples were divided into aliquots and tested in duplicate per ELISA plate on 3 different days in 4 different laboratories (Bristol, Ghent, Hannover, Uppsala). The within- and between-laboratory repeatability of the ELISA was assessed by random effect models and the amount of variance attributable to each source of variation (duplicate within plate, day, laboratory and sample) was expressed as a proportion of the total between-sample variance. Overall, the within-laboratory repeatability was good in each laboratory with a proportion of total between-sample variance that could be attributed to assay variability of 5% in Ghent to 27% in Bristol. The between-laboratory repeatability was high: 15% of the total between-sample variance was attributable to the duplicate, 1% to the day, 2% to the laboratory and 82% to the sample. The range of deviations expected to include 95% of the observations when the same sample is tested in different laboratories was -0.23 to 0.23. The mean difference between the ODR values when the optical density was read at a single or double wavelength was -0.002 and the 95% confidence interval included zero. This study demonstrates that the SVANOVIR(O). ostertagi ELISA has a good repeatability and can be further simplified by reading optical density at a single instead of double wavelength. However, the observed variations in the within-laboratory repeatabilities suggest that regular ring testing is necessary when different laboratories cooperate in a same monitoring programme.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.vetpar.2009.04.013 | DOI Listing |
Ann Clin Biochem
December 2024
Clinical Analysis Laboratory, Hospital Puerta del Mar, Cádiz, España.
A case involving the incidental diagnosis of multiple myeloma (MM) due to interference in the 25-hydroxy-vitamin D (25(OH) vitamin D) immunoassay is presented. The patient, under the care of rheumatology and receiving treatment with alendronic acid and vitamin D supplements, was referred to endocrinology for investigation of acromegaly. Acromegaly was subsequently ruled out; however, during the investigations, consistently elevated levels of 25(OH) vitamin D were noted, raising suspicion of vitamin D resistance syndrome.
View Article and Find Full Text PDFClin Chem Lab Med
August 2024
Department of Emergency Medicine, Christchurch Hospital, Christchurch, New Zealand.
Objectives: The Siemens Point-of-Care Testing (POC) Atellica VTLi high-sensitivity troponin I (hsTnI) device has been previously validated. Verification independently provides evidence that an analytical procedure fulfils concordance with laboratory assays, imprecision, and hemolysis interference requirements.
Methods: Five whole blood samples spanning the measuring interval were analysed 20 times in succession.
J Sci Med Sport
August 2024
School of Health Sciences, Western Sydney University, Australia. Electronic address: https://twitter.com/DNorrisSC.
Objectives: To evaluate the criterion and longitudinal validity of field- and laboratory-derived heart rate (HR) indices of resting and submaximal fitness tests (SMFTs) as measures of cardiorespiratory fitness.
Design: Observational, repeated measures.
Methods: Twenty-nine semi-professional footballers participated.
Clin Cardiol
February 2024
Department of Cardiology, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, China.
To date, the predictive role of laboratory indicators for the phenomenon of no flow is unclear. Hence, our objective was to conduct a meta-analysis to investigate the association between laboratory parameters and the risk of the no-reflow phenomenon in patients with ST-elevation myocardial infarction (STEMI) following primary percutaneous coronary intervention (PCI). This, in turn, aims to offer valuable insights for early clinical prediction of no-reflow.
View Article and Find Full Text PDFLipids Health Dis
January 2024
The Ruth and Bruce Rappaport Faculty of Medicine, Technion - Israel Institute of Technology, Haifa, Israel.
Background: Measurement of the plasma lipid profile, mainly low-density lipoprotein cholesterol (LDL-C), is widely used in the management of hospitalized patients as part of their cardiometabolic risk assessment. In common practice, LDL-C is calculated indirectly by the Friedewald equation. For many years, fasting of 8-14 h is needed to obtain an accurate lipid profile measurement, although recent guidelines do not necessitate it.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!